HB 1301 Pennsylvania House · 2025-2026 Regular Session

An Act requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.

HB 1301 requires all health insurance policies sold in Pennsylvania to cover pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) HIV medications, along with associated lab tests and doctor visits for counseling or prescription, with no copays, deductibles, or coinsurance. It prohibits insurers from placing PrEP/PEP services in specialty tiers for profit and bans requiring specialist counseling unless medically necessary. The law applies to all health insurance policies issued or renewed in Pennsylvania after its effective date (60 days from passage), including group and individual plans regulated under state insurance laws. This directly affects Pennsylvanians with health insurance who need HIV prevention or treatment services, ensuring full coverage without out-of-pocket costs.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
Governor
Introduced Apr 28, 2025 Last action Apr 28, 2025